Recent neuroimaging and postmortem studies have demonstrated abnormalities in glutamatergic transmission in major depression. Glutamate NMDA (N-methyl-D-aspartate) receptors are one of the major mediators of excitatory neurotransmission in the central nervous system. At synaptic sites, NMDA receptors are linked with postsynaptic density protein-95 (PSD-95) that plays a key role in mediating trafficking, clustering, and downstream signaling events, following receptor activation. In this study, we examined the expression of NMDA receptor subunits NR1, NR2A, and NR2B as well as PSD-95 in the anterior prefrontal cortex (PFC) using Western blot method. Cortical samples were obtained from age, gender and postmortem interval matched depressed and psychiatrically healthy controls. The results revealed that there was a reduced expression of the NMDA receptor subunits NR2A (−54%) and NR2B (−48%), and PSD-95 protein level (−40%) in the PFC of depressed subjects relative to controls, with no change in the NR1 subunit. The alterations in NMDA receptor subunits, especially the NR2A and NR2B, as well as PSD-95 suggest an abnormality in the NMDA receptor signaling in the PFC in major depression. Our findings in conjunction with recent clinical, cellular, and neuroimaging studies further implicate the involvement of glutamate neurotransmission in the pathophysiology of depression. This study provides additional evidence that NMDA receptor complex is a target for discovery of novel antidepressants.
Introduction
A disturbance of glutamatergic transmission in the central nervous system has been suggested to contribute to the pathophysiology of major depressive disorder (MDD) . The N-methyl-D-aspartate (NMDA) receptor has received the most attention with respect to the biology of depression and its treatment (for recent reviews see Kugaya and Sanacora, 2005; Pittenger et al., 2007) . Furthermore, there is evidence for efficacy of NMDA receptor antagonists in depression. For example, drugs that modulate NMDA receptor functional activity have demonstrated antidepressant-like properties in animal models. Functional antagonists of the NMDA receptor including ligands at the glutamate, glycine, polyamine and ionophore recognition sites have demonstrated similar activity to currently marketed antidepressants in a range of preclinical screening procedures (for reviews see Paul and Skolnick, 2003; Kugaya and Sanacora, 2005) . Clinically, ketamine, an NMDA receptor channel blocker, produces robust and rapid antidepressant effects in treatmentresistant depression (Berman et al., 2000; Zarate et al., 2006) .
Ionotropic glutamate receptors are the principal mediators of fast excitatory neurotransmission in the central nervous system. These receptors include three subfamilies: alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), kainate, and NMDA receptors. The NMDA receptors are tetrameric complexes composed of obligatory NR1 subunits co-assembled with varying expression of NR2 family of subunits, i.e. NR2(A-D) and less commonly NR3(A-B) subunits. At synaptic sites, NMDA receptors are clustered and anchored to the postsynaptic membrane via a family of specialized proteins which contain PDZ (Postsynaptic density 95, Discs large, and Zonula occludens-1) binding domains (Kornau et al., 1995; Cousins et al., 2008) . Postsynaptic density-95 (PSD-95) is a prominent example of a postsynaptic protein (Kornau et al., 1995; Sheng and Kim, 2002) , which belongs to a membrane associated guanylate kinase (MAGUK) family of scaffold proteins. It contains three PDZ binding domains, which enable anchoring of NMDA receptors via the C-terminal of NR2 subunits (Ziff, 1997) . In addition to their role as scaffolding protein for the NMDA receptor, PSD-95 is required for receptor trafficking, signaling, membrane targeting and internalization of receptor complexes.
Previously, we have demonstrated increased protein expression of specific subunits of the NMDA receptor in the locus coeruleus (LC) and amygdala from depressed subjects (Karolewicz et al., 2005, in press 
